Forbes on pharma whistleblowers

Now here's an article of the type you don't see very often--a defense of pharma industry, specifically in the TAP/AstraZenica whistleblowing cases. Definitely an interesting read!

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.